In this Alpha Wolf Trading Interview with Aclarion Inc stock ticker symbol ACON, CEO Brent Ness, you will learn about Brent's extensive background in the medical industry. You will hear why Brent believes Aclarion has a game-changing product that can help an estimated 260 million people that suffer from chronic back pain. Aclarion's Artificial intelligence, algorithms, and biomarkers help subjectively pinpoint why patients are experiencing that pain with a noninvasive, lower-cost alternative to what is commonly used today. Brent speaks about the path to Aclarion's success and the vision he and his team have to achieve sustainable long-term growth that will benefit doctors, insurers, and, most importantly, patients. Aclarion has the data that shows the effectiveness with more studies on the way.
Brent explains that a good amount of money and time has gone into getting Aclarion to this point, and there are several milestones to look for as an investor. Brent also talks about the corporate culture at Aclarion and how everyone on their team is passionate about the company's future, and they are also incentivized.
IF YOU OR SOMEONE YOU KNOW SUFFERS FROM BACK PAIN. GET IN TOUCH WITH ACLARION AND FIND OUT WHAT THE CAUSE OF THAT PAIN IS TO MAKE AN INFORMED DECISION ON HOW TO ADDRESS IT! https://aclarion.com/clinical/
If you would like to learn how to identify, research, and invest in stocks, below is a link to our website:
We love to teach people the right way to invest.